WAVE Life Sciences Ltd (NAS:WVE)
$ 13.84 0.05 (0.36%) Market Cap: 2.10 Bil Enterprise Value: 1.97 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 53/100

Q4 2022 WAVE Life Sciences Ltd Earnings Call Transcript

Mar 22, 2023 / 12:30PM GMT
Release Date Price: $3.8 (-10.38%)
Operator

Good morning, and welcome to the Wave Life Sciences Fourth Quarter and Full Year 2022 Financial Results Conference Call. (Operator Instructions) As a reminder, this call is being recorded and webcast.

I'll now turn the call over to [Kia Khaleghpour] Wave's IR Consultant. Please go ahead.

Unidentified Company Representative

Thank you, operator. Good morning, and thank you for joining us today to discuss our recent business progress and review Wave's Fourth Quarter and Full Year 2022 financial results. Joining me today are Dr. Paul Bolno, President and Chief Executive Officer; Anne-Marie Li-Kwai-Cheung, Chief Development Officer; Kyle Moran, Chief Financial Officer; and Dr. Chandra Vargeese, Chief Technology Officer.

The press release issued this morning and the slide presentation to accompany this webcast are available on the Investors section of our website at www.wavelifesciences.com.

Before we begin, I would like to remind you that discussions during this conference

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot